93 related articles for article (PubMed ID: 22615316)
1. Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression.
Wu S; Kanda T; Imazeki F; Nakamoto S; Tanaka T; Arai M; Roger T; Shirasawa H; Nomura F; Yokosuka O
J Infect Dis; 2012 Aug; 206(3):415-20. PubMed ID: 22615316
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B e Antigen Inhibits NF-κB Activity by Interrupting K63-Linked Ubiquitination of NEMO.
Wang Y; Cui L; Yang G; Zhan J; Guo L; Chen Y; Fan C; Liu D; Guo D
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404796
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of receptor-interacting serine/threonine protein kinase-2 (RIPK2) affects EMT-associated gene expression in human hepatoma cells.
Wu S; Kanda T; Nakamoto S; Imazeki F; Yokosuka O
Anticancer Res; 2012 Sep; 32(9):3775-83. PubMed ID: 22993319
[TBL] [Abstract][Full Text] [Related]
4. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
6. A short isoform of NOD2/CARD15, NOD2-S, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways.
Rosenstiel P; Huse K; Till A; Hampe J; Hellmig S; Sina C; Billmann S; von Kampen O; Waetzig GH; Platzer M; Seegert D; Schreiber S
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3280-5. PubMed ID: 16492792
[TBL] [Abstract][Full Text] [Related]
7. The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes.
Wilson R; Warner N; Ryan K; Selleck L; Colledge D; Rodgers S; Li K; Revill P; Locarnini S
J Viral Hepat; 2011 Oct; 18(10):e499-507. PubMed ID: 21914069
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen.
Jegaskanda S; Ahn SH; Skinner N; Thompson AJ; Ngyuen T; Holmes J; De Rose R; Navis M; Winnall WR; Kramski M; Bernardi G; Bayliss J; Colledge D; Sozzi V; Visvanathan K; Locarnini SA; Kent SJ; Revill PA
J Virol; 2014 Sep; 88(18):10412-20. PubMed ID: 24872585
[TBL] [Abstract][Full Text] [Related]
9. Cell death gene expression profile: role of RIPK2 in dengue virus-mediated apoptosis.
Morchang A; Yasamut U; Netsawang J; Noisakran S; Wongwiwat W; Songprakhon P; Srisawat C; Puttikhunt C; Kasinrerk W; Malasit P; Yenchitsomanus PT; Limjindaporn T
Virus Res; 2011 Mar; 156(1-2):25-34. PubMed ID: 21195733
[TBL] [Abstract][Full Text] [Related]
10. Human hepatitis B viral e antigen interacts with cellular interleukin-1 receptor accessory protein and triggers interleukin-1 response.
Yang CY; Kuo TH; Ting LP
J Biol Chem; 2006 Nov; 281(45):34525-36. PubMed ID: 16973626
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1-receptor-associated kinase 2 (IRAK2)-mediated interleukin-1-dependent nuclear factor kappaB transactivation in Saos2 cells requires the Akt/protein kinase B kinase.
Cenni V; Sirri A; De Pol A; Maraldi NM; Marmiroli S
Biochem J; 2003 Nov; 376(Pt 1):303-11. PubMed ID: 12906710
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway.
Xiang WQ; Feng WF; Ke W; Sun Z; Chen Z; Liu W
J Hepatol; 2011 Jan; 54(1):26-33. PubMed ID: 20937539
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of IL-6 production by astaxanthin via ERK-, MSK-, and NF-κB-mediated signals in activated microglia.
Kim YH; Koh HK; Kim DS
Int Immunopharmacol; 2010 Dec; 10(12):1560-72. PubMed ID: 20932499
[TBL] [Abstract][Full Text] [Related]
14. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
15. Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae.
Opitz B; Förster S; Hocke AC; Maass M; Schmeck B; Hippenstiel S; Suttorp N; Krüll M
Circ Res; 2005 Feb; 96(3):319-26. PubMed ID: 15653568
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines.
Wu S; Kanda T; Imazeki F; Arai M; Yonemitsu Y; Nakamoto S; Fujiwara K; Fukai K; Nomura F; Yokosuka O
Viral Immunol; 2010 Oct; 23(5):467-76. PubMed ID: 20883161
[TBL] [Abstract][Full Text] [Related]
17. The flavonoid ellagic acid from a medicinal herb inhibits host immune tolerance induced by the hepatitis B virus-e antigen.
Kang EH; Kown TY; Oh GT; Park WF; Park SI; Park SK; Lee YI
Antiviral Res; 2006 Nov; 72(2):100-6. PubMed ID: 16720052
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-κB.
Pan X; Cao H; Lu J; Shu X; Xiong X; Hong X; Xu Q; Zhu H; Li G; Shen G
Mol Immunol; 2011 Jul; 48(12-13):1573-7. PubMed ID: 21481941
[TBL] [Abstract][Full Text] [Related]
19. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion.
Yuen MF; Wong DK; Zheng BJ; Chan CC; Yuen JC; Wong BC; Lai CL
J Viral Hepat; 2007 Apr; 14(4):269-75. PubMed ID: 17381719
[TBL] [Abstract][Full Text] [Related]
20. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
